v3.26.3
Segment Information - Summary of Segment Information for Revenue, Significant Segment Expenses and Net Loss as Regularly Provided to the CODM (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Jun. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
Segment Reporting [Line Items]                
Stock-based compensation expense $ 1,281     $ 1,254     $ 2,939 $ 4,091
Loss from operations (8,887)     (8,980)     (28,251) (27,550)
Interest expense (2)     (2)     (5) (8)
Other income, net 836     1,168     2,665 3,511
Net loss (8,053) $ (9,139) $ (8,399) (7,814) $ (8,046) $ (8,187) (25,591) (24,047)
Single Reporting Segment                
Segment Reporting [Line Items]                
Revenue 42     16     86 71
Cost of revenue 61     41     153 122
Payroll related expenses 4,225     4,360     14,310 12,252
Consulting and professional fees 1,450     1,514     5,014 5,389
Stock-based compensation expense 1,281     1,254     2,939 4,091
Equipment, lab supplies, and facility expenses 369     422     1,036 1,225
Clinical studies and outside processing 111     394     387 1,111
Depreciation and amortization [1] 163     214     489 609
Other segment items [2] 1,269     797     4,009 2,822
Loss from operations (8,887)     (8,980)     (28,251) (27,550)
Interest expense (2)     (2)     (5) (8)
Other income, net 836     1,168     2,665 3,511
Net loss $ (8,053)     $ (7,814)     $ (25,591) $ (24,047)
[1] Certain amortization amounts are included within cost of revenue.
[2] Other segment items consist primarily of insurance costs, IT services, travel expenses, marketing expenses, taxes, and other miscellaneous expenses.